D. Richardson, D. Kalinowski, S. Lau, P. Jansson, and D. Lovejoy, Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1790, issue.7, pp.702-719, 2009.
DOI : 10.1016/j.bbagen.2008.04.003

D. Richardson, Therapeutic Potential of Iron Chelators in Cancer Therapy, Adv Exp Med Biol, vol.509, pp.231-280, 2002.
DOI : 10.1007/978-1-4615-0593-8_12

D. Lane, T. Mills, N. Shafie, A. Merlot, S. Moussa et al., Expanding horizons in iron chelation and the treatment of cancer: Role of iron in the regulation of ER stress and the epithelial???mesenchymal transition, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1845, issue.2, pp.166-81, 2014.
DOI : 10.1016/j.bbcan.2014.01.005

D. Richardson and P. Ponka, The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells, Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, vol.1331, issue.1, pp.1-40, 1997.
DOI : 10.1016/S0304-4157(96)00014-7

J. Kwok and D. Richardson, The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Critical reviews in oncology, hematology, vol.42, pp.65-78, 2002.

M. Brookes, S. Hughes, F. Turner, G. Reynolds, N. Sharma et al., Modulation of iron transport proteins in human colorectal carcinogenesis, Gut, vol.55, issue.10, pp.1449-60, 2006.
DOI : 10.1136/gut.2006.094060

S. Torti and F. Torti, Iron and cancer: more ore to be mined, Nature Reviews Cancer, vol.69, issue.5, pp.342-55, 2013.
DOI : 10.1038/nrc3495

A. Merlot, D. Kalinowski, and D. Richardson, Novel chelators for cancer treatment: where are we now? Antioxidants & redox signaling, pp.973-1006, 2013.

G. Lescoat, K. Chantrel-groussard, N. Pasdeloup, H. Nick, P. Brissot et al., Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism, Cell Proliferation, vol.24, issue.5, pp.755-67, 2007.
DOI : 10.1042/BJ20031327

T. Thomas and T. Thomas, Polyamine metabolism and cancer. Journal of cellular and molecular medicine, pp.113-139, 2003.

H. Wallace, A. Fraser, and A. Hughes, A perspective of polyamine metabolism, Biochemical Journal, vol.376, issue.1, pp.1-14, 2003.
DOI : 10.1042/bj20031327

N. Babbar and E. Gerner, Targeting polyamines and inflammation for cancer prevention. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer, pp.49-64, 2011.

J. Annereau, V. Brel, C. Dumontet, Y. Guminski, T. Imbert et al., A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment, Leukemia Research, vol.34, issue.10, pp.1383-1392, 2010.
DOI : 10.1016/j.leukres.2009.12.021

J. Barret, A. Kruczynski, S. Vispe, J. Annereau, V. Brel et al., F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System, Cancer Research, vol.68, issue.23, pp.9845-53, 2008.
DOI : 10.1158/0008-5472.CAN-08-2748

URL : https://hal.archives-ouvertes.fr/inserm-00353546

R. Bergeron, J. Mcmanis, A. Franklin, H. Yao, and W. Weimar, Polyamine???Iron Chelator Conjugate, Journal of Medicinal Chemistry, vol.46, issue.25, pp.5478-83, 2003.
DOI : 10.1021/jm0302694

R. Bergeron, S. Singh, N. Bharti, and Y. Jiang, Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators, Synthesis, vol.2010, issue.21, pp.3631-3637, 2010.
DOI : 10.1055/s-0030-1258245

M. Burns, G. Graminski, R. Weeks, Y. Chen, O. Brien et al., Lipophilic Lysine???Spermine Conjugates Are Potent Polyamine Transport Inhibitors for Use in Combination with a Polyamine Biosynthesis Inhibitor, Journal of Medicinal Chemistry, vol.52, issue.7, pp.1983-93, 2009.
DOI : 10.1021/jm801580w

L. Covassin, M. Desjardins, R. Charestgaudreault, M. Audette, M. Bonneau et al., Synthesis of spermidine and norspermidine dimers as high affinity polyamine transport inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.9, issue.12, pp.1709-1723, 1999.
DOI : 10.1016/S0960-894X(99)00262-0

S. Dallavalle, G. Giannini, D. Alloatti, A. Casati, E. Marastoni et al., Synthesis and Cytotoxic Activity of Polyamine Analogues of Camptothecin, Journal of Medicinal Chemistry, vol.49, issue.17, pp.5177-86, 2006.
DOI : 10.1021/jm060285b

J. Delcros, S. Tomasi, S. Carrington, B. Martin, R. J. Blagbrough et al., Effect of Spermine Conjugation on the Cytotoxicity and Cellular Transport of Acridine, Journal of Medicinal Chemistry, vol.45, issue.23, pp.5098-111, 2002.
DOI : 10.1021/jm020843w

J. Delcros, M. Vaultier, N. Roch, R. Havouis, J. Moulinoux et al., Bis(7-amino-4- azaheptyl)dimethylsilane: a new tetramine with polyamine-like features. Effects on cell growth, Anticancer Drug design, vol.12, pp.35-48, 1997.

A. Esteves-souza, K. Lucio, D. Cunha, A. , D. C. Pinto et al., Antitumoral activity of new polyamine-naphthoquinone conjugates, Oncology Reports, vol.20, pp.225-256, 2008.
DOI : 10.3892/or.20.1.225

R. Gardner, M. Belting, K. Svensson, and I. O. Phanstiel, Synthesis and Transfection Efficiencies of New Lipophilic Polyamines, Journal of Medicinal Chemistry, vol.50, issue.2, pp.308-326, 2007.
DOI : 10.1021/jm0607101

J. Holley, A. Mather, P. Cullis, M. Symons, P. Wardman et al., Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in ehrlich ascites tumour cells, Biochemical Pharmacology, vol.43, issue.4, pp.763-772, 1992.
DOI : 10.1016/0006-2952(92)90241-A

R. Verschoyle, P. Carthew, J. Holley, P. Cullis, and G. Cohen, The comparative toxicity of chlorambucil and chlorambucil-spermidine conjugate to BALBc mice, Cancer Letters, vol.85, issue.2, pp.217-239, 1994.
DOI : 10.1016/0304-3835(94)90278-X

J. Zhuo, J. Cai, A. Soloway, R. Barth, D. Adams et al., Synthesis and Biological Evaluation of Boron-Containing Polyamines as Potential Agents for Neutron Capture Therapy of Brain Tumors, Journal of Medicinal Chemistry, vol.42, issue.7, pp.1282-92, 1999.
DOI : 10.1021/jm980703f

V. Corce, E. Morin, S. Guiheneuf, R. E. Renaud, S. Cannie et al., Polyaminoquinoline Iron Chelators for Vectorization of Antiproliferative Agents: Design, Synthesis, and Validation, Bioconjugate Chemistry, vol.23, issue.9, pp.1952-68, 2012.
DOI : 10.1021/bc300324c

URL : https://hal.archives-ouvertes.fr/inserm-00863636

V. Corce, S. Renaud, I. Cannie, J. K. Gouin, S. Loreal et al., Synthesis and Biological Properties of Quilamines II, New Iron Chelators with Antiproliferative Activities, Bioconjugate Chemistry, vol.25, issue.2, pp.320-354, 2014.
DOI : 10.1021/bc4004734

D. Rodbard and S. Mcclean, Automated computer analysis for enzyme-multiplied immunological techniques, Clinical chemistry, vol.23, pp.112-117, 1977.

V. Quemener, Y. Blanchard, L. Chamaillard, R. Havouis, B. Cipolla et al., Polyamine deprivation: a new tool in cancer treatment, Anticancer Res, vol.14, pp.443-451, 1994.

F. Gaboriau, R. Havouis, J. Moulinoux, and J. Delcros, Atmospheric pressure chemical ionization-mass spectrometry method to improve the determination of dansylated polyamines, Analytical Biochemistry, vol.318, issue.2, pp.212-232, 2003.
DOI : 10.1016/S0003-2697(03)00214-8

N. Seiler, Use of the Dansyl Reaction in Biochemical Analysis, Methods Biochem Anal, vol.18, pp.259-337, 1970.
DOI : 10.1002/9780470110362.ch5

V. Ducros, D. Ruffieux, H. Belva-besnet, F. De-fraipont, F. Berger et al., Determination of dansylated polyamines in red blood cells by liquid chromatography???tandem mass spectrometry, Analytical Biochemistry, vol.390, issue.1, pp.46-51, 2009.
DOI : 10.1016/j.ab.2009.04.007

URL : https://hal.archives-ouvertes.fr/inserm-00527601

G. Lescoat, L. Gouffier, I. Cannie, O. Lowe, I. Morel et al., Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines, Molecular and Cellular Biochemistry, vol.10, issue.1, pp.205-220, 2013.
DOI : 10.1007/s11010-013-1611-0

URL : https://hal.archives-ouvertes.fr/inserm-00831699

W. Heston, D. Kadmon, D. Covey, and W. Fair, Differential effect of a-difluorométhylornithine on the in vivo uptake of 14 C-labeled polyamines and méthylglyoxal bis(guanylhydrazone) by a rat prostatederived tumor, Cancer Res, vol.44, pp.1034-1074, 1984.

V. Quemener, J. Moulinoux, R. Havouis, and N. Seiler, Polyamine deprivation enhances antitumoral efficacy of chemotherapy, Anticancer Res, vol.12, pp.1447-53, 1992.

E. Løvaas, Antioxidative and metal-chelating effects of polyamines Antioxidants in disease mechanisms and therapy, pp.116-165, 1997.

B. Palmer and H. Powell, Polyamine complexes with seven-membered chelate rings: complex formation of 3-azaheptane-1,7-diamine, 4-azaoctane-1,8-diamine (spermidine), and 4,9-diazadodecane-1,12-diamine (spermine) with copper(II) and hydrogen ions in aqueous solution, Journal of the Chemical Society, Dalton Transactions, vol.1974, issue.19, pp.2089-92
DOI : 10.1039/dt9740002089

G. Lescoat, S. Leonce, A. Pierre, L. Gouffier, and F. Gaboriau, Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures, Chemico-Biological Interactions, vol.195, issue.2, pp.165-72, 2011.
DOI : 10.1016/j.cbi.2011.12.003

J. Moulinoux, V. Quemener, J. Delcros, and B. Cipolla, Circulating polyamines as biological markers for cancer Polyamines in cancer : Basic mechanisms and clinical approaches, pp.233-50, 1996.